Activity of genacitabine/5-FU combination in refractory esophagogastrie (EG) cancer.

被引：0
|
作者：
Won, Elizabeth [1 ]
Ilson, David H. [1 ]
Chou, Joanne F. [1 ]
Capanu, Marinela [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15073
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activity of gemcitabine/5-FU combination in refractory esophagogastric (EG) cancer.
    Won, Elizabeth
    Ilson, David H.
    Chou, Joanne F.
    Capanu, Marinela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Evaluation of oxaliplatin, 5-FU and leucovorin maintenance treatment in refractory metastatic colon cancer.
    Headlee, C
    Beasley, S
    Jackson, D
    Teel, C
    Mirtsching, BC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 278S - 278S
  • [3] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Phase II study of 5-FU/LV/lrinotecan in combination with regional hyperthermia (RHT) in 5-FU/Lv refractory patients with advanced colorectal cancer
    Krych, M
    Lindner, LH
    Abele, S
    Abdel-Rahman, S
    Fahn, W
    Milani, V
    Braun, S
    Stockheim, B
    Heinemann, V
    Issels, RD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 301S - 301S
  • [5] A phase II trial of gefitinib in combination with 5-FU/LV/irinotecan in patients with colorectal cancer.
    Redlinger, M
    Kramer, A
    Flaherty, K
    Sun, W
    Haller, D
    O'Dwyer, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 310S - 310S
  • [6] Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
    Yamanaka H.
    Motohiro T.
    Michiura T.
    Asai A.
    Mori T.
    Hioki K.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (10): : 943 - 948
  • [7] Measurements of 5-FU levels in plasma of patients with gastrointestinal cancer.
    Blaschke, Martina
    Cameron, Silke
    Blumberg, Jutta
    Wegner, Ulrike
    Ramadori, Giuliano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [8] Predictive markers for 5-FU resistance in metastatic breast cancer.
    Christensen, AJ
    Jensen, LB
    Balslev, E
    Nielsen, KV
    Poulsen, TS
    Nielsen, DL
    Moller, S
    Mouridsen, H
    Ejlertsen, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S55 - S55
  • [9] Effect of resveratrol and in combination with 5-FU on murine liver cancer
    Wu, Sheng-Li
    Sun, Zhong-Jie
    Yu, Liang
    Meng, Ke-Wei
    Qin, Xing-Lei
    Pan, Cheng-En
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (20) : 3048 - 3052
  • [10] Effect of resveratrol and in combination with 5-FU on murine liver cancer
    Sheng-Li Wu Zhong-Jie Sun Liang Yu Ke-Wei Meng Xing-Lei Qin Cheng-En Pan Department of Hepatobiliary Surgery
    World Journal of Gastroenterology, 2004, (20) : 3048 - 3052
12345